Long-term secondary prevention and outcome following acute coronary syndrome: real-world results from the Swedish Primary Care Cardiovascular Database

被引:4
作者
Bentzel, Sara [1 ,2 ]
Ljungman, Charlotta [1 ,2 ]
Hjerpe, Per [3 ,4 ]
Schioler, Linus [5 ]
Manhem, Karin [6 ]
Bostrom, Kristina Bengtsson
Kahan, Thomas [7 ]
Mourtzinis, Georgios [1 ,8 ]
机构
[1] Gothenburg Univ, Sahlgrenska Acad, Dept Mol & Clin Med, Inst Med, Bla Straket 5B Wallenberglab SU, S-41345 Gothenburg, Sweden
[2] Sahlgrens Univ Hosp, Dept Cardiol, Bla Straket 3, S-41346 Gothenburg, Sweden
[3] Univ Gothenburg, Inst Med, Sahlgrenska Acad, Sch Publ Hlth & Community Med, Gothenburg, Sweden
[4] Reg Halsan R&D Ctr, Skaraborg Primary Care, Skovde, Sweden
[5] Univ Gothenburg, Inst Med, Sch Publ Hlth & Community Med, Occupat & Environm Med,Sahlgrenska Acad, Gothenburg, Sweden
[6] Univ Gothenburg, Sahlgrenska Univ Hosp, Inst Med, Sahlgrenska Acad,Dept Mol & Clin Med, Gothenburg, Sweden
[7] Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Div Cardiovasc Med, Stockholm, Sweden
[8] Sahlgrens Univ Hosp, Dept Med & Emergency Molndal, Molndal, Sweden
关键词
Coronary artery disease; Risk factors; Secondary prevention; Treatment adherence; EUROPEAN-SOCIETY; GUIDELINES; RISK; HYPERTENSION; MANAGEMENT;
D O I
10.1093/eurjpc/zwad389
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Most studies of treatment adherence after acute coronary syndrome (ACS) are based on prescribed drugs and lack long-term follow-up or consecutive data on risk factor control. We studied the long-term treatment adherence, risk factor control, and its association to recurrent ACS and death.Methods and results We retrospectively included 3765 patients (mean age 75 years, 40% women) with incident ACS from 1 January 2006 until 31 December 2010 from the Swedish Primary Care Cardiovascular Database of Skaraborg. All patients were followed until 31 December 2014 or death. We recorded blood pressure (BP), low-density lipoprotein cholesterol (LDL-C), recurrent ACS, and death. We used data on dispensed drugs to calculate the proportion of days covered for secondary prevention medications. Cox regressions were used to analyse the association of achieved BP and LDL-C to recurrent ACS and death. The median follow-up time was 4.8 years. The proportion of patients that reached BP of <140/90 mm Hg was 58% at Year 1 and 66% at Year 8. 65% of the patients reached LDL-C of <2.5 mmol/L at Year 1 and 56% at Year 8; however, adherence to statins varied from 43% to 60%. Only 62% of the patients had yearly measured BP, and only 28% yearly measured LDL-C. Systolic BP was not associated with a higher risk of recurrent ACS or death. Low-density lipoprotein cholesterol of 3.0 mmol/L was associated with a higher risk of recurrent ACS {hazard ratio [HR] 1.19 [95% confidence interval (CI) 1.00-1.40]} and death HR [1.26 (95% CI 1.08-1.47)] compared with an LDL-C of 1.8 mmol/L.Conclusion This observational long-term real-world study demonstrates low drug adherence and potential for improvement of risk factors after ACS. Furthermore, the study confirms that uncontrolled LDL-C is associated with adverse outcome even in this older population.Lay summary In this real-world retrospective observational study, we followed 3765 elderly patients for up to 8 years after incident acute coronary syndrome.center dot Only a low proportion of the studied population had yearly measured blood pressure and cholesterol, a low proportion had satisfied risk factor control (blood pressure and cholesterol), and adherence to secondary prevention medication was low.center dot In this elderly population (mean age 75 years), higher levels of low-density lipoprotein cholesterol were associated with a higher risk of recurrent coronary event and death.
引用
收藏
页码:812 / 821
页数:10
相关论文
共 44 条
  • [1] [Anonymous], 2023, SWEDEHEART ANN REPOR
  • [2] [Anonymous], 2015, SWEDEHEART Annual report 2014.
  • [3] Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical Trial
    Bach, Richard G.
    Cannon, Christopher P.
    Giugliano, Robert P.
    White, Jennifer A.
    Lokhnygina, Yuliya
    Bohula, Erin A.
    Califf, Robert M.
    Braunwald, Eugene
    Blazing, Michael A.
    [J]. JAMA CARDIOLOGY, 2019, 4 (09) : 846 - 854
  • [4] Trends in blood pressure, blood lipids, and smoking from 259 753 patients with hypertension in a Swedish primary care register: results from QregPV
    Bager, Johan-Emil
    Mourtzinis, Georgios
    Andersson, Tobias
    Natman, Jonatan
    Rosengren, Annika
    Bjorck, Staffan
    Manhem, Karin
    Hjerpe, Per
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (01) : 158 - 166
  • [5] Hypertension treatment in the oldest-old: focus group interviews with Swedish general practitioners
    Berkhout, Marjo
    Bostrom, Kristina Bengtsson
    Ostberg, Anna-Lena
    [J]. SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2022, 40 (03) : 395 - 404
  • [6] The Swedish cause of death register
    Brooke, Hannah Louise
    Talback, Mats
    Hornblad, Jesper
    Johansson, Lars Age
    Ludvigsson, Jonas Filip
    Druid, Henrik
    Feychting, Maria
    Ljung, Rickard
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2017, 32 (09) : 765 - 773
  • [7] Effectiveness of lipid-lowering therapy on mortality and major adverse cardiovascular event outcomes in patients undergoing percutaneous coronary intervention: a network meta-analysis of randomised controlled trials
    Deng, Chang-Jiang
    Yan, Ju
    Zheng, Ying-Ying
    Wu, Ting-Ting
    Pan, Ying
    Hou, Xian-Geng
    Wang, Si-Fan
    Sirajidin, Subinur
    Aimaitijiang, Mikereyi
    Xie, Xiang
    [J]. BMJ OPEN, 2023, 13 (11):
  • [8] Treatment Patterns of Lipid-Lowering Therapy in Patients with Coronary Artery Disease Aged Above and Below 75 Years: A Retrospective Cross-Sectional Study of 1500 Patients in a Tertiary Care Referral Center in Germany
    Dykun, Iryna
    Wiefhoff, Daniela
    Totzeck, Matthias
    Al-Rashid, Fadi
    Janosi, R. Alexander
    Hendricks, Stefanie
    Rassaf, Tienush
    Mahabadi, Amir A.
    [J]. DRUGS & AGING, 2020, 37 (07) : 521 - 527
  • [9] Time-dependent covariates in the Cox proportional-hazards regression model
    Fisher, LD
    Lin, DY
    [J]. ANNUAL REVIEW OF PUBLIC HEALTH, 1999, 20 : 145 - 157
  • [10] Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
    Fulcher, Jordan
    Mihaylova, Borislaya
    O'Connell, Rachel
    Emberson, Jonathan
    Blackwell, Lisa
    Reith, Christina
    Koren, Michael
    Tonkin, Andrew
    Ridker, Paul
    Barnes, Elizabeth
    Ford, Ian
    Packard, Chris
    Lonn, Eva
    Wanner, Christoph
    Koenig, Wolfgang
    Gotto, Antonio
    Kjekshus, John
    Yusuf, Salim
    Collins, Rory
    Simes, John
    Baigent, Colin
    Keech, Anthony
    de Lemos, J.
    Braunwald, E.
    Blazing, M.
    Murphy, S.
    Downs, J. R.
    Gotto, A.
    Clearfield, M.
    Holdaas, H.
    Gordon, D.
    Davis, B.
    Koren, M.
    Dahlof, B.
    Poulter, N.
    Sever, P.
    Knopp, R. H.
    Fellstrom, B.
    Jardine, A.
    Schmieder, R.
    Zannad, F.
    Colhoun, H. M.
    Betteridge, D. J.
    Durrington, P. N.
    Hitman, G. A.
    Fuller, J.
    Neil, A.
    Sacks, F.
    Moye, L.
    Pfeffer, M.
    [J]. LANCET, 2019, 393 (10170) : 407 - 415